The RECORD Study of Avandia Side Effects

The RECORD study has been touted as the largest study ever done in regards to Avandia side effects.  The study tracked more than 4,400 diabetics, some of whom took Avandia and others who took two older diabetes drugs, metformin and sulfonylurea.  The purpose of the study was to draw a comparison between the development of commonly alleged Avandia side effects - heart attacks, strokes and other pulmonary problems - in those who used Avandia and those who used the other drugs.  The conclusion of the RECORD study has been published, and it basically states that there is no link between the use of Avandia and an increased risk of heart disease, heart failure, and other alleged Avandia side effects.

 

The FDA's Reaction to the RECORD Avandia Side Effects Study

The FDA received and reviewed the conclusions of the RECORD study, and its response was basically to excoriate the results.  Using candor that's rare for this regulatory body, a spokesperson for the FDA noted that RECORD used sloppy data, failed to follow up on reports of the development of potential Avandia side effects and that overall the study was biased and inappropriate in several ways.  This reaction comes just one day before the process of deciding whether or not Avandia will remain on the market begins.

Unfortunately for many people who have already suffered from dangerous Avandia side effects, the decision regarding whether it remains on the market will not undo the damage already done.  If you or someone you love has suffered as a result of using this medication, you need to contact the Avandia side effects lawyers at Atkins & Markoff immediately to schedule a free initial consultation.